Search Results - "Chhina, Jasdeep"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Bioenergetic Adaptations in Chemoresistant Ovarian Cancer Cells by Dar, Sajad, Chhina, Jasdeep, Mert, Ismail, Chitale, Dhananjay, Buekers, Thomas, Kaur, Hareena, Giri, Shailendra, Munkarah, Adnan, Rattan, Ramandeep

    Published in Scientific reports (18-08-2017)
    “…Earlier investigations have revealed that tumor cells undergo metabolic reprogramming and mainly derive their cellular energy from aerobic glycolysis rather…”
    Get full text
    Journal Article
  2. 2

    Risk of ESRD and Mortality in Kidney and Bladder Stone Formers by Dhondup, Tsering, Kittanamongkolchai, Wonngarm, Vaughan, Lisa E., Mehta, Ramila A., Chhina, Jasdeep K., Enders, Felicity T., Hickson, LaTonya J., Lieske, John C., Rule, Andrew D.

    Published in American journal of kidney diseases (01-12-2018)
    “…[Display omitted] Kidney stones have been associated with increased risk for end-stage renal disease (ESRD). However, it is unclear whether there is also an…”
    Get full text
    Journal Article
  3. 3

    Folic acid tagged nanoceria as a novel therapeutic agent in ovarian cancer by Hijaz, Miriana, Das, Soumen, Mert, Ismail, Gupta, Ankur, Al-Wahab, Zaid, Tebbe, Calvin, Dar, Sajad, Chhina, Jasdeep, Giri, Shailendra, Munkarah, Adnan, Seal, Sudipta, Rattan, Ramandeep

    Published in BMC cancer (15-03-2016)
    “…Nanomedicine is a very promising field and nanomedical drugs have recently been used as therapeutic agents against cancer. In a previous study, we showed that…”
    Get full text
    Journal Article
  4. 4

    Metformin limits the adipocyte tumor-promoting effect on ovarian cancer by Tebbe, Calvin, Chhina, Jasdeep, Dar, Sajad A, Sarigiannis, Kalli, Giri, Shailendra, Munkarah, Adnan R, Rattan, Ramandeep

    Published in Oncotarget (15-07-2014)
    “…Omental adipocytes promote ovarian cancer by secretion of adipokines, cytokines and growth factors, and acting as fuel depots. We investigated if metformin…”
    Get full text
    Journal Article
  5. 5

    Synergistic effect of MEK inhibitor and metformin combination in low grade serous ovarian cancer by Mert, Ismail, Chhina, Jasdeep, Allo, Ghassan, Dai, Jing, Seward, Shelly, Carey, Mark S., Llaurado, Marta, Giri, Shailendra, Rattan, Ramandeep, Munkarah, Adnan R.

    Published in Gynecologic oncology (01-08-2017)
    “…•Metformin inhibits LGSOC cells.•Trametinib inhibits LGSOC with RAS mutation.•Synergistic effect of Metformin and Trametinib depends on RAS…”
    Get full text
    Journal Article
  6. 6

    Targeting of free fatty acid receptor 1 in EOC: A novel strategy to restrict the adipocyte-EOC dependence by Munkarah, Adnan, Mert, Ismail, Chhina, Jasdeep, Hamid, Suhail, Poisson, Laila, Hensley-Alford, Sharon, Giri, Shailendra, Rattan, Ramandeep

    Published in Gynecologic oncology (01-04-2016)
    “…Abstract Objectives Adipocyte derived free fatty acids (FFA) promote epithelial ovarian cancer (EOC) by acting as a fuel source to support the energy…”
    Get full text
    Journal Article
  7. 7

    Abstract 11: Metformin exerts differential metabolic effects in ovarian cancer cell lines by Munkarah, Adnan, Poisson, Laila, Kim, Seongho, Chhina, Jasdeep, Giri, Shailendra, Rattan, Ramandeep

    Published in Cancer research (Chicago, Ill.) (15-07-2016)
    “…Metformin is being actively repurposed for treatment of gynecologic malignancies including ovarian cancer, with various clinical trials underway. Metformin is…”
    Get full text
    Journal Article
  8. 8

    Metformin prevents aggressive ovarian cancer growth driven by high-energy diet: similarity with calorie restriction by Al-Wahab, Zaid, Mert, Ismail, Tebbe, Calvin, Chhina, Jasdeep, Hijaz, Miriana, Morris, Robert T, Ali-Fehmi, Rouba, Giri, Shailendra, Munkarah, Adnan R, Rattan, Ramandeep

    Published in Oncotarget (10-05-2015)
    “…Caloric restriction (CR) was recently demonstrated by us to restrict ovarian cancer growth in vivo. CR resulted in activation of energy regulating enzymes…”
    Get full text
    Journal Article
  9. 9

    Abstract A81: Targeting of free fatty acid signaling in ovarian cancer may serve as a potential therapeutic approach by Munkarah, Adnan, Hamid, Suhail, Chhina, Jasdeep, Mert, Ismail, Jackson, LaToya, Hensley-Alford, Sharon, Chitale, Dhananjay, Giri, Shailendra, Rattan, Ramandeep

    Published in Clinical cancer research (15-01-2016)
    “…Recent studies have revealed an association between adipocyte driven free fatty acids (FFA) and the aggressiveness of epithelial ovarian cancer (EOC)…”
    Get full text
    Journal Article
  10. 10

    Dietary energy balance modulates ovarian cancer progression and metastasis by Al-Wahab, Zaid, Tebbe, Calvin, Chhina, Jasdeep, Dar, Sajad A, Morris, Robert T, Ali-Fehmi, Rouba, Giri, Shailendra, Munkarah, Adnan R, Rattan, Ramandeep

    Published in Oncotarget (15-08-2014)
    “…A high energy balance, or caloric excess, accounts as a tumor promoting factor, while a negative energy balance via caloric restriction, has been shown to…”
    Get full text
    Journal Article
  11. 11

    Abstract B77: Targeting ovarian cancer promoting effects of adipocytes by metformin by Rattan, Ramandeep, Tebbe, Calvin, Chhina, Jasdeep, Sarigiannis, Kalli, Giri, Shailendra, Munkarah, Adnan

    Published in Clinical cancer research (01-10-2013)
    “…At the time of surgery, 80% of the ovarian cancers are found to be metastasized to the omentum, a large fat pad covering the abdominal organs. Omental…”
    Get full text
    Journal Article